Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company’s best-in-class product offerings include Arteriocyte’s market-leading Magellan® Autologous Platelet Separator and Isto’s bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; and Influx™, a natural bone-graft material.

Biotechnology

Health Care

Medical Devices

Therapeutics

Isto Biologics

Donald Brown

Kathy Carl

Jessica Kemp

Christine Schroeder

Amit Govil

Jerry Keefe

Ganfeng Wu

Brian Barnes

Nathan Taylor

Isto Biologics

Org chart

Teams

Offices

Similar companies